Development of a gene-deleted live attenuated candidate vaccine against fish virus (ISKNV) with low pathogenicity and high protection

Aquaculture provides important food, nutrition, and income sources for humans. However, aquaculture industry is seriously threatened by viral diseases. Infectious spleen and kidney necrosis virus (ISKNV) disease causes high mortality and economic losses to the fish culture industry in Asia and has been listed as a certifiable disease by the International Epizootic Office. Vaccine development is urgent to control this disease. Here, a gene-deleted live attenuated candidate vaccine (Delta ORF022L) against ISKNV with low pathogenicity and high protection was developed. Delta ORF022L replicated well inmandarin fish fry-1 cells and showed similar structure with wild-type ISKNV. However, the pathogenicity was significantly lower as 98% of the mandarin fish infected with Delta ORF022L survived, whereas all those infected with wild-type ISKNV died. Of importance, 100% of the Delta ORF022L-infected fish survived the ISKNV challenge. Delta ORF022L induced anti-ISKNV specific antibody response and upregulation of immune-related genes. This work could be beneficial to the control of fish diseases.

Automated summary

The study developed a gene-deleted live attenuated candidate vaccine against ISKNV, which showed low pathogenicity and high protection in experimental studies, indicating potential benefits for controlling fish diseases.